NJSの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/12/05 | 2,897 | 2,925 | 2,883 | 2,890 | -19 | -0.7% | 17,500 |
2023/12/04 | 2,875 | 2,910 | 2,842 | 2,909 | +56 | +2% | 19,700 |
2023/12/01 | 2,830 | 2,887 | 2,827 | 2,853 | +26 | +0.9% | 23,000 |
2023/11/30 | 2,805 | 2,827 | 2,745 | 2,827 | -3 | -0.1% | 48,800 |
2023/11/29 | 2,777 | 2,850 | 2,748 | 2,830 | +170 | +6.4% | 102,700 |
2023/11/28 | 2,656 | 2,672 | 2,652 | 2,660 | -11 | -0.4% | 13,000 |
2023/11/27 | 2,668 | 2,671 | 2,643 | 2,671 | +27 | +1% | 12,900 |
2023/11/24 | 2,646 | 2,664 | 2,629 | 2,644 | +24 | +0.9% | 18,700 |
2023/11/22 | 2,618 | 2,658 | 2,618 | 2,620 | -9 | -0.3% | 40,600 |
2023/11/21 | 2,690 | 2,690 | 2,628 | 2,629 | -46 | -1.7% | 72,300 |
2023/11/20 | 2,651 | 2,689 | 2,651 | 2,675 | +14 | +0.5% | 42,800 |
2023/11/17 | 2,627 | 2,661 | 2,613 | 2,661 | +44 | +1.7% | 37,900 |
2023/11/16 | 2,611 | 2,668 | 2,606 | 2,617 | +3 | +0.1% | 35,000 |
2023/11/15 | 2,623 | 2,651 | 2,612 | 2,614 | -28 | -1.1% | 31,700 |
2023/11/14 | 2,648 | 2,648 | 2,618 | 2,642 | -10 | -0.4% | 23,600 |
2023/11/13 | 2,707 | 2,715 | 2,651 | 2,652 | -37 | -1.4% | 25,300 |
2023/11/10 | 2,750 | 2,781 | 2,608 | 2,689 | -110 | -3.9% | 54,300 |
2023/11/09 | 2,761 | 2,802 | 2,761 | 2,799 | +23 | +0.8% | 12,000 |
2023/11/08 | 2,825 | 2,925 | 2,770 | 2,776 | -41 | -1.5% | 19,500 |
2023/11/07 | 2,833 | 2,862 | 2,803 | 2,817 | -50 | -1.7% | 18,300 |
2023/11/06 | 2,880 | 2,900 | 2,852 | 2,867 | +18 | +0.6% | 18,200 |
2023/11/02 | 2,855 | 2,867 | 2,849 | 2,849 | +6 | +0.2% | 12,200 |
2023/11/01 | 2,822 | 2,848 | 2,804 | 2,843 | +48 | +1.7% | 15,400 |
2023/10/31 | 2,760 | 2,795 | 2,740 | 2,795 | ±0 | ±0% | 14,000 |
2023/10/30 | 2,790 | 2,840 | 2,775 | 2,795 | +5 | +0.2% | 14,300 |
2023/10/27 | 2,732 | 2,790 | 2,732 | 2,790 | +48 | +1.8% | 13,900 |
2023/10/26 | 2,744 | 2,779 | 2,735 | 2,742 | -15 | -0.5% | 17,000 |
2023/10/25 | 2,809 | 2,809 | 2,742 | 2,757 | -15 | -0.5% | 21,200 |
2023/10/24 | 2,738 | 2,777 | 2,690 | 2,772 | +32 | +1.2% | 19,600 |
2023/10/23 | 2,800 | 2,821 | 2,732 | 2,740 | -59 | -2.1% | 16,400 |
2023/10/20 | 2,784 | 2,827 | 2,748 | 2,799 | +16 | +0.6% | 13,400 |
2023/10/19 | 2,796 | 2,805 | 2,755 | 2,783 | -19 | -0.7% | 12,800 |
2023/10/18 | 2,787 | 2,814 | 2,773 | 2,802 | +7 | +0.3% | 15,100 |
2023/10/17 | 2,794 | 2,825 | 2,776 | 2,795 | +35 | +1.3% | 13,400 |
2023/10/16 | 2,819 | 2,825 | 2,758 | 2,760 | -59 | -2.1% | 12,200 |
2023/10/13 | 2,866 | 2,866 | 2,819 | 2,819 | -56 | -1.9% | 9,400 |
2023/10/12 | 2,887 | 2,887 | 2,843 | 2,875 | +8 | +0.3% | 7,900 |
2023/10/11 | 2,905 | 2,942 | 2,852 | 2,867 | -33 | -1.1% | 15,300 |
2023/10/10 | 2,916 | 2,963 | 2,888 | 2,900 | +14 | +0.5% | 8,200 |
2023/10/06 | 2,837 | 2,904 | 2,837 | 2,886 | +29 | +1% | 10,400 |
2023/10/05 | 2,799 | 2,895 | 2,799 | 2,857 | +60 | +2.1% | 15,600 |
2023/10/04 | 2,915 | 2,915 | 2,797 | 2,797 | -161 | -5.4% | 23,500 |
2023/10/03 | 2,967 | 3,005 | 2,931 | 2,958 | -5 | -0.2% | 18,400 |
2023/10/02 | 3,005 | 3,005 | 2,963 | 2,963 | -42 | -1.4% | 29,100 |
2023/09/29 | 2,999 | 3,010 | 2,963 | 3,005 | +23 | +0.8% | 8,700 |
2023/09/28 | 3,010 | 3,015 | 2,967 | 2,982 | -63 | -2.1% | 18,400 |
2023/09/27 | 2,984 | 3,045 | 2,972 | 3,045 | +73 | +2.5% | 18,700 |
2023/09/26 | 3,010 | 3,010 | 2,972 | 2,972 | -33 | -1.1% | 10,600 |
2023/09/25 | 3,010 | 3,025 | 2,999 | 3,005 | +5 | +0.2% | 24,700 |
2023/09/22 | 2,980 | 3,010 | 2,978 | 3,000 | +11 | +0.4% | 15,900 |
201~
250
件表示中 / 5391件
類似銘柄と比較する
現在ご覧いただいている「NJS」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
NJS | 342,000円 | +2.2% | +73.1% | 2.78% | 15.50倍 | 1.22倍 |
|
上下水道のコンサルタント。官公需がほとんど。調査から設計・施工監理まで一貫。海外拠点多数 |
ワールドHD | 194,800円 | +17.9% | -15.9% | 4.15% | 7.36倍 | 0.86倍 |
|
製造派遣・請負が主力。技術者・研究者派遣や大都市で土地・マンション分譲も。配当性向3割 |
シーティーエス | 82,600円 | +8.2% | +5.9% | 3.03% | 17.50倍 | 2.83倍 |
|
建設ICTの専門会社。現場向けITインフラ、測量計測機器軸に全国展開。配当は業績に連動 |
WDB | 171,000円 | +5.1% | -13.4% | 3.54% | 11.31倍 | 1.12倍 |
|
理学系研究職や研究補助職の人材派遣で首位。医薬品開発受託(CRO)や医薬関連事務も |
アイロムG | 277,500円 | - | - | - | - | 2.63倍 |
|
SMO(医療機関向け治験支援)主力。日・豪でCRO(医薬品開発受託)。MBO実施準備 |
市場注目の銘柄
チャート関連のコラム